ID: ALA556131

Max Phase: Preclinical

Molecular Formula: C14H23ClN2

Molecular Weight: 218.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCN1CCCC(c2cccc(N)c2)C1.Cl

Standard InChI:  InChI=1S/C14H22N2.ClH/c1-2-8-16-9-4-6-13(11-16)12-5-3-7-14(15)10-12;/h3,5,7,10,13H,2,4,6,8-9,11,15H2,1H3;1H

Standard InChI Key:  GWLUVEXOMYTFLE-UHFFFAOYSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 218.34Molecular Weight (Monoisotopic): 218.1783AlogP: 2.86#Rotatable Bonds: 3
Polar Surface Area: 29.26Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 2.59CX LogD: 0.23
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -0.99

References

1. Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A..  (1981)  3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.,  24  (12): [PMID:6796690] [10.1021/jm00144a021]

Source